NOEMI
MANCEÑIDO MARCOS
PROFESOR DOCTOR
![Foto de Federico](/img/nophoto.png)
Federico
Argüelles Arias
Federico Argüelles Arias-rekin lankidetzan egindako argitalpenak (5)
2022
-
Co-09. Efectividad y seguridad de ustekinumab en enfermedad de crohn en pacientes bionaive: Un estudio multicéntrico
Revista andaluza de patología digestiva, Vol. 45, Núm. 5, pp. 206-208
-
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
Frontiers in Medicine, Vol. 9
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
2017
-
Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis
Inflammatory Bowel Diseases, Vol. 23, Núm. 8, pp. 1394-1402